Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancer

BACKGROUND: Generalizable population-based studies are unable to account for individual tumor heterogeneity that contributes to variability in a patient’s response to physician-chosen therapy. Although molecular characterization of tumors has advanced precision medicine, in early-stage and locally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Joseph R., Cole, John A., Pfeiffer, John R., Norris, Gregory H., Zhang, Yuhan, Lopez-Ramos, Dorys, Pandey, Tushar, Biancalana, Matthew, Esslinger, Hope R., Antony, Anuja K., Takiar, Vinita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170712/
https://www.ncbi.nlm.nih.gov/pubmed/37165441
http://dx.doi.org/10.1186/s13058-023-01654-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170712/
https://www.ncbi.nlm.nih.gov/pubmed/37165441
http://dx.doi.org/10.1186/s13058-023-01654-z

Ejemplares similares